supply of sterilizers, disinfectant devices, and air purifiers that can facilitate rapid turnaround of sterilized or disinfected medical equipment and that help reduce the risk of viral exposure for patients and health care providers to SARS-CoV-2. FDA believes that certain sterilizers, disinfectant devices, and air purifiers falling within the scope of this guidance (see Section III) may help reduce this risk of viral exposure based on our current understanding of these devices and SARS-CoV-2.Coronaviruses are RNA viruses enveloped in a lipid bilayer.9,10 SARS-CoV-2 is a type of coronavirus. As depicted in Figure 1, lipid viruses are the least resistant microorganisms on the scale of descending order of resistance to germicidal chemicals.11 Because sterilization processes render devices free from viable microorganisms including bacterial spores, and because disinfection kills most recognized pathogenic microorganisms, it can generally be inferred that sterilization and disinfection should minimize the viability of SARS-CoV-2 (as one of the least resistant microorganisms) on surfaces and in the air in confined spaces. Moreover, air purifiers can be designed to filter out virus-sized particles.
提供消毒器、消毒裝置和空氣凈化器,可促進消毒或消毒醫療設備的快速周轉,並有助於降低患者和衛生保健提供者接觸SARS-CoV-2病毒的風險。FDA 認為,根據我們目前對這些設備和 SARS-CoV-2 的瞭解,屬於本指南範圍內的某些消毒器、消毒設備和空氣凈化器(參見第三節)可能有助於降低病毒暴露的風險。<br>冠狀病毒是包裹在脂質層中的RNA病毒。 9,10 SARS-CoV-2是一種冠狀病毒。如圖1所示,脂質病毒是抗殺菌化學品的降序下抗藥性最低的微生物。此外,空氣凈化器可以設計來過濾出病毒大小的顆粒。
正在翻译中..